Search results
Rear Admiral. Steven Kenneth Galson (born 1956) is an American public health physician. He is currently a Senior Advisor at the Boston Consulting Group and Independent Board Member at Biocryst Pharmaceuticals [4] and Elephas Biosciences [5]. Until 2021 he was Senior Vice President for Research and Development at Amgen, the California-based ...
- 1986–2009
- Rear Admiral
Steven K. Galson, MD, MPH, is a senior advisor at BCG and serves as Independent Director on the Boards of Biocryst Pharmaceuticals and Elephas Biosciences. Until June 2020, he was a senior vice president of Research and Development at Amgen. He joined the company in 2010 as vice president of Global Regulatory Affairs.
Dr. Steven K. Galson, senior vice president, Global Regulatory Affairs and Safety, joined Amgen in 2010 as vice president, Global Regulatory Affairs. Prior to Amgen, Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation.
People also ask
Who is Steven Galson?
Who is John Galson & what did he do before Amgen?
What did John Galson do in 2009?
Where did John Galson get his medical degree?
Aug 19, 2021 · Steven K. Galson, MD, MPH, retired from Amgen in July after almost 12 years in senior roles in research and development including senior vice president, global regulatory affairs and safety....
Mar 1, 2009 · Mental Health Matters - Steven K. Galson, 2009. Free access. Research article. First published online March 1, 2009. Mental Health Matters. Steven K. Galson, MD, MPH, RADM, USPHS View all authors and affiliations. Volume 124, Issue 2. https://doi.org/10.1177/003335490912400202. Contents. PDF / ePub. More. References. 1. World Health Organization.
Mar 29, 2023 · Steven K. Galson, MD, MPH, is a senior advisor at BCG and serves as Independent Director on the Boards of Biocryst Pharmaceuticals and Elephas Biosciences. Until June 2020, he was a senior vice president of Research and Development at Amgen.
Steven K. Galson, MD, MPH, is a senior advisor to Boston Consulting Group and serves on the board of directors of Biocryst Pharmaceuticals and Elephas Biosciences. Until June 2020, he was a senior vice president of Research and Development at Amgen.